COLUMBUS, Ohio — Ohio’s technology development project — the Third Frontier — has granted $6 million to two biomedical commercialization efforts in the state, according to the Ohio Department of Development.
A consortium headed by the Cleveland Clinic will get $3 million to develop and take to market medical devices made from nitinol — an alloy of nickel and titanium that is well-accepted by the body and springs back into a predetermined shape when it is heated.
Highland Heights contract manufacturer Norman Noble Inc., University of Toledo, Case Western Reserve University and NASA Glenn Research Center also belong to the consortium plans to commercialize an adjustable tube for heart-assist devices, screws for spine repair, a suture clip that would replace hand-stitches and a device to help patients who can’t raise their feet regain the ability to walk.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The University of Cincinnati will receive $3 million to develop and commercialize a technology that strengthens materials used to make medical devices. Laser shock peening technology treats the surface of materials to make them stronger, longer-lived and resistant to cracks.
Though the technology will initially be used to treat medical device materials, it could later be applied to materials used in other industries.
The University of Cincinnati consortium also comprises X-Spine Systems Inc., LSP Technologies Inc., UES Inc., and Cincinnati State Technical and Community College.
The grants are being made through the project’s Wright Project program that supports near-term commercialization efforts that require major capital acquisitions and improvements at Ohio colleges, universities and research institutions. The grants must be approved by the Ohio Controlling Board, the Development Department said.
